Compare Brevis (BREV) vs Immunefi (IMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Immunefi — how do they compare? Brevis trades at Rp1,346 (market cap Rp333,86M, Rp236,1M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Brevis is far larger — about 12.4× Immunefi's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Immunefi for 5 Days on average.
| BREV | IMU | |
|---|---|---|
Market Cap | Rp333,86M | Rp27,03M |
Volume (24h) | Rp236,1M | Rp39,91M |
Circulating Supply | 250M / 1B BREV (25%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 6 Days | 5 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
